Clinical Research, Pharma & Healthcare FinancingInnoCare Gets OK to Trial Mesutoclax for MDS in ChinaBusiness WireMay 29, 2025August 1, 2025 by Business WireMay 29, 2025August 1, 20250144 InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the Investigational New Drug (IND)...